<VariationArchive RecordType="classified" VariationID="1339349" VariationName="NM_000424.4(KRT5):c.1321_1332del (p.Lys441_Gln444del)" VariationType="Deletion" Accession="VCV001339349" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-02-05" MostRecentSubmission="2022-02-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1330408" VariationID="1339349">
      <GeneList>
        <Gene Symbol="KRT5" FullName="keratin 5" GeneID="3852" HGNC_ID="HGNC:6442" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>12q13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="52514575" stop="52520394" display_start="52514575" display_stop="52520394" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="52908358" stop="52914242" display_start="52908358" display_stop="52914242" Strand="-" />
          </Location>
          <OMIM>148040</OMIM>
        </Gene>
        <Gene Symbol="LOC126861525" FullName="BRD4-independent group 4 enhancer GRCh37_chr12:52909857-52911056" GeneID="126861525" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>12q13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="52516073" stop="52517272" display_start="52516073" display_stop="52517272" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000424.4(KRT5):c.1321_1332del (p.Lys441_Gln444del)</Name>
      <CanonicalSPDI>NC_000012.12:52516743:CTGCTTGGCCTTCTGC:CTGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="52516744" stop="52516755" display_start="52516744" display_stop="52516755" variantLength="12" positionVCF="52516743" referenceAlleleVCF="CCTGCTTGGCCTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="52910528" stop="52910539" display_start="52910528" display_stop="52910539" variantLength="12" positionVCF="52910527" referenceAlleleVCF="CCTGCTTGGCCTT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.52910532_52910543del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.52910532_52910543del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.52516748_52516759del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.52516748_52516759del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008297.1" sequenceAccession="NG_008297" sequenceVersion="1" change="g.8705_8716del">
            <Expression>NG_008297.1:g.8705_8716del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000424.4" sequenceAccession="NM_000424" sequenceVersion="4" change="c.1321_1332del" MANESelect="true">
            <Expression>NM_000424.4:c.1321_1332del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000415.2" sequenceAccession="NP_000415" sequenceVersion="2" change="p.Lys441_Gln444del">
            <Expression>NP_000415.2:p.Lys441_Gln444del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="148040.0027" DB="OMIM" />
        <XRef Type="rs" ID="2120475630" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000424.4(KRT5):c.1321_1332del (p.Lys441_Gln444del) AND Epidermolysis bullosa simplex with migratory circinate erythema" Accession="RCV001823945" Version="1">
        <ClassifiedConditionList TraitSetID="4041">
          <ClassifiedCondition DB="MedGen" ID="C1836284">Epidermolysis bullosa simplex with migratory circinate erythema</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-02-05" MostRecentSubmission="2022-02-05">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">29180315</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4041" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1161" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex with migratory circinate erythema</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+Simplex/8318" DB="Genetic Alliance" />
                <XRef ID="716700003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EBS-migr</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex 2E, with migratory circinate erythema</ElementValue>
                <XRef ID="MONDO:0012258" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16990" />
                <XRef ID="16990" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.</Attribute>
                <XRef ID="NBK1369" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301543</ID>
                <ID Source="BookShelf">NBK1369</ID>
              </Citation>
              <XRef ID="158681" DB="Orphanet" />
              <XRef ID="C1836284" DB="MedGen" />
              <XRef ID="MONDO:0012258" DB="MONDO" />
              <XRef Type="MIM" ID="609352" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4063835" SubmissionDate="2022-02-02" DateLastUpdated="2022-02-05" DateCreated="2022-02-05">
        <ClinVarSubmissionID localKey="148040.0027_EPIDERMOLYSIS BULLOSA SIMPLEX 2E, WITH MIGRATORY CIRCINATE ERYTHEMA" title="KRT5, 12-BP DEL, NT1321_EPIDERMOLYSIS BULLOSA SIMPLEX 2E, WITH MIGRATORY CIRCINATE ERYTHEMA" />
        <ClinVarAccession Accession="SCV002073537" DateUpdated="2022-02-05" DateCreated="2022-02-05" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 9-year-old Korean boy who had EBS with migratory circinate erythema (EBS2E; 609352), Lee et al. (2018) identified heterozygosity for a de novo in-frame 12-bp deletion (c.1321_1332del12) in exon 7 of the KRT5 gene, causing deletion of 3 amino acids (Lys441_Gln444del) from the 2B domain. The mutation was not found in his unaffected parents or in public variant databases. Unlike previously reported patients with EBS2E, the proband did not develop migratory circinate erythema until 9 years of age.</Attribute>
              <Citation>
                <ID Source="PubMed">29180315</ID>
              </Citation>
              <XRef DB="OMIM" ID="609352" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KRT5" />
          </GeneList>
          <Name>KRT5, 12-BP DEL, NT1321</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">12-BP DEL, NT1321</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="148040.0027" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA SIMPLEX 2E, WITH MIGRATORY CIRCINATE ERYTHEMA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4063835" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA SIMPLEX 2E, WITH MIGRATORY CIRCINATE ERYTHEMA" MappingRef="Preferred">
        <MedGen CUI="C1836284" Name="Epidermolysis bullosa simplex with migratory circinate erythema" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

